Semaglutide is mostly effectively tolerated with equivalent dropout premiums compared with placebo, although it may be considerably less effectively tolerated than dulaglutide (Trulicity).1,three The most common adverse results are nausea, vomiting, and diarrhea and may be expert by about 30% of